Operating profit before deduction of amortization: Ocean Biomedical (OCEA)
Ocean Biomedical, Inc. (OCEA) monetizes developments in cancer immunotherapy and malaria vaccination by utilizing software robots to analyze clinical data. The GURU.Markets platform broadcasts the total EBITDA for the period, where the indicator expresses the state of the metric. Ocean Biomedical, Inc. (OCEA) functions as a biopharmaceutical incubator, creating an efficient channel to bring fundamental oncological discoveries from universities to the commercial market.
Ocean Biomedical (OCEA) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt level and financial liquidity data:
Debt to Equity Ratio Ocean Biomedical, Inc.|OCEA - Long-Term Debt to Capital|Current Liabilities to Capital Ocean Biomedical Inc|OCEA - Company Debts|Debts to Book Value Ocean Biomedical|OCEA - Company Long-Term Debts|Company Current Liabilities Ocean Biomedical|Immediate Liquidity oceanbiomedical.com
- earnings and multiples data:
OCEA - Net Profit|Projected Future Earnings Ocean Biomedical, Inc.|OCEA - Price to Earnings Ratio|Price to Future Earnings Ratio oceanbiomedical.com|OCEA - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Ocean Biomedical|OCEA - Operating profit EBITDA|Earnings per share for the last twelve months Ocean Biomedical|OCEA - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months oceanbiomedical.com|OCEA - Earnings per share growth in current year|Expected net earnings per share growth next year Ocean Biomedical, Inc.
Analysis of all company metrics:Ocean Biomedical, Inc.
Absolute operating profit measures net cash flow from core operations, demonstrating the business's ability to generate liquidity excluding debt service and depreciation. By analyzing the EBITDA history, an investor assesses the financial stability of Ocean Biomedical, Inc. (OCEA), which is critical during the preclinical trial and vaccine development stage when operational activity remains moderate prior to the launch of breakthrough releases.
Who Ocean Biomedical, Inc. competes with
Operating income before deduction of amortization argenx BVBA (ARGX)|BNTX - Profit before payment of interest, taxes and amortization|Abivax S.A. (ABVX) - Operating profit before deduction of amortization|ADMA Biologics, Inc. (ADMA) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Protagonist Therapeutics, Inc.|Operating profit before deduction of amortization IMVT|Operating profit EBITDA Kiniksa Corp|Profit before payment of interest, taxes and amortization Grifols, S.A. (GRFS)|adaptivebiotech.com - Operating profit before amortization|Operating profit EBITDA CLDX (Celldex Therapeutics, Inc.)|Aurinia Pharmaceuticals Inc (AUPH) - Profit before interest, taxes and amortization|BCRX - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Vera Corp|DNTH: Operating profit EBITDA|Operating profit before deduction of amortization pharvaris.com|ABCL (AbCellera Biologics Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization Tourmaline Bio Inc TRML|Operating profit EBITDA PGEN|Operating profit EBITDA Pharming Corp (PHAR)|Profit before payment of interest, taxes and amortization Nektar Therapeutics NKTR|UPB: Operating profit before amortization|ZBIO: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization IMNM (Immunome Inc)|GOSS: Operating profit EBITDA|KALV (KalVista Corp) - Profit before payment of interest, taxes and amortization|SEPN (Septerna Inc) - Operating profit EBITDA|pieris.com (PVLA) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Savara (SVRA)|RIGL - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization AnaptysBio Corp ANAB|ATXS - Operating profit before deduction of amortization|enGene Holdings Inc. - Operating profit EBITDA|Profit before interest, taxes and amortization RAPT Therapeutics Inc.|JBIO: Operating profit EBITDA|Operating profit before amortization ACRS|KYTX (Kyverna) - Operating profit EBITDA|Tiziana Life Sciences, Ltd. (TLSA) - Operating income before deduction of amortization|Operating profit EBITDA CABA|Operating profit before deduction of amortization ventyxbio.com VTYX|Operating profit EBITDA THTX (Theratechnologies)|Operating profit EBITDA Avalo Therapeutics, Inc. AVTX|ELDN - Profit before payment of interest, taxes and amortization|AGEN: Profit before payment of interest, taxes and amortization|CLYM (Climb Bio Inc) - Operating profit before deduction of amortization|Zura Bio Ltd - Income before deduction of interest, taxes and amortization|ATYR (aTyr Pharma) - Operating profit EBITDA|Adagene Corp (ADAG) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization ImageneBio Inc (IMA)|shattucklabs.com - Operating profit before amortization|Operating profit EBITDA EQ (Equillium)|CNTB - Operating profit before deduction of amortization|IMUX: Operating profit before deduction of amortization|Operating income before deduction of amortization Atara Biotherapeutics ATRA|inflarx.de (IFRX) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization X4 Pharmaceuticals, Inc (XFOR)|ACET (Adicet Bio Inc.) - Operating profit EBITDA|Operating profit before deduction of amortization Celularity Corp (CELU)|Operating profit EBITDA INMB|BRNS - Profit before interest, taxes and amortization|Operating profit EBITDA KZR (Kezar Life Sciences, Inc)|Operating profit EBITDA SAB Biotherapeutics Inc SABS|AKTX - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization ENLV|QTTB: Operating profit EBITDA|GeoVax Labs - Income before deduction of interest, taxes and amortization|EDSA (Edesa) - Operating profit EBITDA|Operating profit EBITDA iBio Corporation|Profit before payment of interest, taxes and amortization Carisma Therapeutics (CARM)|XTLB (xtlbio.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Bolt Biotherapeutics, Inc. BOLT|HCWB - Operating profit before deduction of amortization|Aptevo - Operating profit EBITDA|AIM - Operating profit EBITDA|ADTX (aditxt.com) - Operating profit before deduction of amortization|gribio.com - Income before deduction of interest, taxes and amortization|XRTX (XORTX Therapeutics) - Operating profit EBITDA|Vyome Holdings Inc. (HIND) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Revelation Bio (REVB)|Operating profit before deduction of amortization Indaptus Corp INDP|Profit before payment of interest, taxes and amortization Scinai Immunotherapeutics SCNI|CALI - Operating profit before deduction of amortization|AFMD: Operating profit before deduction of amortization|ALLK - Operating profit EBITDA|hookipapharma.com (HOOK) - Profit before payment of interest, taxes and amortization|Operating profit before amortization IGMS|ITOS (iTeos Therapeutics) - Operating profit EBITDA|Profit before interest, taxes and amortization tcbiopharm.com TCBP|Profit before payment of interest, taxes and amortization Third Harmonic Bio, Inc. (THRD)
